MLDL1278A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MLDL1278A, covering 2012-12-11 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER) [Phase 2]